首页 | 本学科首页   官方微博 | 高级检索  
   检索      

多重耐药寡养单胞菌的基因组学研究进展
引用本文:唐宇航,方诗琦,谢琳琳,孙超,李珊珊,周爱萍,曹广祥,李骏.多重耐药寡养单胞菌的基因组学研究进展[J].生物工程学报,2023,39(4):1314-1331.
作者姓名:唐宇航  方诗琦  谢琳琳  孙超  李珊珊  周爱萍  曹广祥  李骏
作者单位:浙江工业大学生物工程学院, 浙江杭州 310032;江西农业大学食品科学与工程学院, 江西 南昌 330045;上海市东方医院, 上海 200123;上海市东方医院吉安医院, 江西 吉安 343000;山东第一医科大学(山东省医学科学院) 生物医学科学学院&山东省医药生物技术研究中心, 山东 济南 250117
基金项目:国家自然科学基金(31800118,32260032);江西双千计划(jxsq2019101054);江西省自然科学基金(20171BAB205110)
摘    要:寡养单胞菌(Stenotrophomonas)是一类广泛分布于自然环境中的革兰氏阴性非发酵细菌,环境适应能力较强,尤其具备高度耐受抗生素的能力,被认为是耐药基因(antimicrobial resistance,AMR)传播的“物流转运仓库”。临床上寡养单胞菌检出率逐年提高,且耐受抗生素能力及其种类呈现增加态势。本文围绕寡养单胞菌基因组编码的多样性耐药因子,结合基因组学工具开发、抗生素耐药分子机制的研究进展,针对耐药相关因子所涉及的进化/变异和序列编辑技术展开综述。寡养单胞菌的比较基因组学(comparative genomics)研究,可推动耐药菌高效监测与扩散风险防控、解析微生物适应环境关键机制和设计靶向药物。

关 键 词:寡养单胞菌  基因组学  多重抗生素耐药  传播风险
收稿时间:2022/7/6 0:00:00

Advances in genomics of multi-drug resistant Stenotrophomonas
TANG Yuhang,FANG Shiqi,XIE Linlin,SUN Chao,LI Shanshan,ZHOU Aiping,CAO Guangxiang,LI Jun.Advances in genomics of multi-drug resistant Stenotrophomonas[J].Chinese Journal of Biotechnology,2023,39(4):1314-1331.
Authors:TANG Yuhang  FANG Shiqi  XIE Linlin  SUN Chao  LI Shanshan  ZHOU Aiping  CAO Guangxiang  LI Jun
Institution:College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310032, Zhejiang, China;College of Food Science and Engineering, Jiangxi Agricultural University, Nanchang 330045, Jiangxi, China;Shanghai East Hospital, Shanghai 200123, China;Shanghai East Hospital Ji''an Hospital, Ji''an 343000, Jiangxi, China;Biomedical Sciences College &Shandong Medicinal Biotechnology Centre, Shandong First Medical University &Shandong Academy of Medical Sciences, Ji''nan 250117, Shandong, China
Abstract:Stenotrophomonas species are non-fermentative Gram-negative bacteria that are widely distributed in environment and are highly resistant to numerous antibiotics. Thus, Stenotrophomonas serves as a reservoir of genes encoding antimicrobial resistance (AMR). The detection rate of Stenotrophomonas is rapidly increasing alongside their strengthening intrinsic ability to tolerate a variety of clinical antibiotics. This review illustrated the current genomics advances of antibiotic resistant Stenotrophomonas, highlighting the importance of precise identification and sequence editing. In addition, AMR diversity and transferability have been assessed by the developed bioinformatics tools. However, the working models of AMR in Stenotrophomonas are cryptic and urgently required to be determined. Comparative genomics is envisioned to facilitate the prevention and control of AMR, as well as to gain insights into bacterial adaptability and drug development.
Keywords:Stenotrophomonas  genomics  multi-drug resistance  transferability risk
点击此处可从《生物工程学报》浏览原始摘要信息
点击此处可从《生物工程学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号